The early embryo implantation is characterized by enhanced uterine vascular permeability at the site of blastocyst attachment, followed by extracellular-matrix remodeling and angiogenesis. Two TG (transglutaminase) isoenzymes, TG2 (tissue TG) and FXIII (factor XIII), catalyze covalent cross-linking of the extracellular-matrix. However, their specific role during embryo implantation is not fully understood.
of intravenously administered vital dyes, and noninvasive detection of embryo implantation by dynamic contrastenhanced (DCE)-magnetic resonance imaging (MRI). 9, 10 Embryo implantation failure is the primary cause for the low rate of success of in vitro fertilization programs. 4 Impaired uterine hyperpermeability has been proposed as a cause for implantation failure in humans. 11 Several complications of pregnancy, such as preeclampsia and intrauterine growth restriction, have been attributed to disturbances in early uterine blood supply 12 or impaired TC invasion of the placental bed spiral arterioles later in pregnancy. 13 TGs (transglutaminases) catalyze covalent cross-links between proteins in various processes associated with angiogenesis and extracellular matrix remodeling, such as wound healing, cancer invasion, and embryo implantation. 14 The most prominent TG isoenzymes are TG2 (tissue TG), that serves as a signaling molecule aside from its cross-linking activity 15, 16 and FXIII (factor XIII), which participates in the final stage of the coagulation cascade, by catalyzing cross-links between fibrinogen or fibrin molecules. 17, 18 In addition to fibrinogen, several extracellular-matrix glycoproteins, such as collagen, were found to be cross-linked by FXIII. [19] [20] [21] We previously reported substrate analogs (SAs) for both TG2 and FXIII, labeled with either Gd (III)-DTPA (diethylenetriaminepentaacetic acid) or DOTA (gadoterate meglumine) or a fluorescent dye were designed to investigate their role in mouse models of tumor xenografts and blood clotting. 22, 23 Selective peptide substrates specific for either TG2 or FXIII were identified by a phage display screen. 24 Given that both TG2 and FXIII are expressed at the embryo-maternal surface during early development, 16, 25 the aim of this study was to determine the distinct roles of TG2 and FXIII in maternal vascular development during embryo implantation in mice. To do so, we successfully synthesized SAs for the 2 enzymes 26, 27 demonstrating a highly selective and specific reactivity to their respective TG isoenzymes. TG2 and FXIII activities were further confirmed by determining the synthetized SAs distributions on IS sections. The contribution of embryo-derived TG activity was assessed by genetically modifying the blastocyst trophectoderm, in which the outer TC underwent lentiviral infection to overexpress TG2 or FXIII or using CRISPR-CAS9 (clustered regularly interspaced short palindromic repeats-associated protein 9) endonuclease to deplete their expression.
Briefly, DCE-MRI of surrogate pregnant mice carrying embryos with FXIII overexpressed TC, revealed a significant decrease in blood volume at the IS regions, while reduction in vessel permeability was demonstrated in embryonic TC overexpressing either FXIII or TG2. Furthermore, IS with FXIII-depleted TC displayed a significant increase vascular permeability, while vasculature changes were not detected in IS of TG2-depleted embryos. These MRI results demonstrate the distinct roles of embryo-derived TG2 and FXIII in maternal vascular remodeling during embryo implantation.
MATERIALS AND METHODS
The data that support the findings of this study are available from the corresponding author on reasonable request.
Synthesis and Characterization of the SAs F11-B and T29-B
All materials were purchased from Sigma-Aldrich Israel Ltd, Rehovot, Israel unless indicated otherwise. T29: REQLYLYNVFS and F11: DQMMLPWPAVKL sequences were based on a phagedisplayed random peptide library screen. 24, 26, 28 Peptides were synthetized by a Liberty CEM microwave peptide synthesizer (CEM SRL, Bergamo, Italy) by standard Fluorenylmethyloxycarbonyl strategy using H-Rink amide ChemMatrix resin (35-100 mesh particle size) as solid support on a 0.1 mmol scale. Peptide coupling was performed in dimethylformamide using the amino acid (4 equivalent), PyBOP (Benzotriazol-1-yloxy) The synthesis  of T29-B also included additional conjugation with 8-amino  3,6-dioxaoctanoic acid linker at the terminal amino group to introduce a spacer between the targeting peptide and biotin. After the automatic synthesis, the resin-peptide (≈0.1 mmol of NH2 -terminated peptide) was mixed with a dimethylformamide solution of biotin-N-hydroxysuccinimide (0.3 mmol, 0.102 g) and N,N-Diisopropylethylamine (0.8 mmol, 0.143 mL). The mixture was stirred at room temperature for 12 hours, and the resin was thoroughly washed with dimethylformamide, dichloromethane, and diethylether. After cleavage and deprotection with trifluoroacetic acid (TFA) /Phenol/water/triisopropylsilane/ethanedithiol (82.5:5:5:5:2.5, v/v), the peptide was precipitated, and the solid was washed with diethyl ether. The solid was lyophilized to give the final product (68 mg, yield 36%, and purity 80% for T29-B and 60 mg, yield 33%, and purity 85% for F11-B). Analytical highperformance liquid chromatography-mass spectrometry (MS; Figure 1A , upper part for T29-B; and Figure 1B Figure 1A , lower part) and F11-B ( Figure 1B , lower part) was used to calculate their concentration, whereas their purification was performed by preparative high-performance liquid chromatography using a buffered solution of ammonium acetate as eluent.
Nonstandard Abbreviations and Abbreviations

TG Activity Assay
TG activity was determined as previously reported 22 Figure 1C ) or FXIII ( Figure 1D ). Reactions were performed, while incubated at 37°C for 1 hour and were stopped by washing with 50 mmol/L ethylenediaminetetraacetic acid. The incorporated SAs were detected using 1:150 streptavidin-alkaline phosphatase with phosphatase substrate. Kinetic measurements of absorbance at 405 nm were determined at 15 seconds intervals for a period of 5 minutes (VICTOR2; Wallac, 1420 Multilabel counter; Winpact Scientific Inc, Irvine, CA). Relative activity of TG2 is expressed as units 
Immunohistochemistry
Uterus sections containing hemizygote embryos of Myr-Venus on E5.5 ( Figure 1A and 1E) or E6.5 Figure 2A and 2E) or surrogate Institute of Cancer Research (ICR) mice carrying embryos with transgenic TC on E6.5 (Figure 2 and 5) were fixed in 4% paraformaldehyde and later embedded in paraffin blocks and sectioned serially at a 4 µm thickness. The paraffin sections were deparaffinized with xylene for 15 minutes, followed by sequential ethanol hydration and double-distilled water. Sections were then washed with PBS followed by antigen retrieval in Citrate (pH 6.0) or ethylenediaminetetraacetic acid (pH 8.5) buffer using a pressure cooker at 125°C for 3 minutes. Thereafter, samples were blocked and permeabilized by 20% horse serum and 0.2% Triton X-100 in PBS. The following primary antibodies were added to the samples and incubated overnight at 4°C: mouse anti-TG2, mouse anti-FXIII (Abcam, Cambridge, United Kingdom) and goat anti-GFP (green fluorescent protein), rat anti-CD34 (cluster of differentiation 34; CEDARLANE, Burlington, NC), anti-CIV (collagen IV) antibody biotin conjugate (600-406-106, Rockland Immunochemicals Inc, Limerick, PA) and rabbit anti-fibrinogen (ab34269; Abcam, Cambridge, United Kingdom). Next, slides were washed with PBS and incubated with the appropriate secondary antibodies diluted 1:150 in PBS for 45 minutes at room temperature: CY5, Cy3, or Cy2-conjugated streptavidin, Cy3 anti-mouse (Jackson Immunoresearch Laboratories, West Grove, PA) or Alexa488 antigoat. Please see the Major Resources Table in the online-only Data Supplement for additional information. Cell nuclei were fluorescently stained with DAPI. The fluorescent signal was detected in ×5, ×10, or ×20 magnifications using a fluorescent microscope (Zeiss Axioscope II, Yena, Germany, Simple PCI software). Images were processed as described earlier using ImageJ software.
Histological Analysis of TG2 and FXIII Activities
SAs T29 for TG2 and F11 for FXIII were synthetized based on a phage-displayed random peptide library screen. 24, 26, 28 Sections of mice uteri were used for histological mapping of TG2 and FXIII activities, according to the method described by Kawamoto 29, 30 with slight modifications. Briefly, 8 to 12 weeks old C57bl/6J female mice (Envigo, Jerusalem, Israel) were mated with Myr-Venus 31 homozygote males to produce hemizygote embryos for Myr-Venus. On E5.5 or E6.5 the dams were injected IV with 0.1 mmol/L of T29-B or F11-B dissolved in PBS with 3% DMSO. Forty-five minutes after injection mice were euthanized, and their uteri were freeze-embedded with optimum cutting temperature compound (Tissue-Tek, Sakura Finetek, CA). Fifteen micrometer thick sections were prepared from the frozen specimen block using a cryomicrotome (Leica Co Ltd, Wetzlar, Germany). Uteri sections of untreated C57bl/6J pregnant mice were used for detecting TG2 and FXIII activities by in situ administration of the SAs. Specificity of the SAs was also observed in situ by inhibiting TG activity with iodoacetamide. Sections were air dried and then blocked with 1% BSA at room temperature for 30 minutes. Sections were then incubated for 60 minutes at 37°C in the substrate reaction solution, consist of 100 mmol/L tris(hydroxymethyl)aminomethane (Tris; pH 8.0), 1 mmol/L dithiothreitol 5 mmol/L CaCl 2 , and T29-B or F11-B at the final concentration of 10 µmol/L. Nonspecific activity of the SAs was detected by adding 1 mg/ mL of iodoacetamide to the reaction solution. Enzymatic reaction was stopped using 50 mmol/L ethylenediaminetetraacetic acid. After fixation, all sections were blocked and incubated with Cy3-streptavidin (Jackson Immunoresearch Laboratories, West Grove, PA). IS with Myr-Venus hemizygote embryos were further treated with 1:500 goat anti-GFP (Abcam, Cambridge, United Kingdom) diluted in 20% horse serum and 0.2% Triton X-100 overnight at 4°C. Sections were treated with Alexa488 anti-goat (Abcam, Cambridge, United Kingdom) and cell nuclei and later stained by DAPI. Samples were observed under a fluorescence microscope using ×10 or ×20 magnifications (Zeiss Axioscope II, Yena, Germany, Simple PCI software). Vessel density was determined with Fluorescence images of anti-CD34 staining 10 using ImageJ software (Wayne Rasband, National Institutes of Health, MD). In brief, under identical conditions the fluorescence intensity of the stained area from the total IS area was measured in absolute counts after applying an automatic threshold. Fluorescent intensity outside the vessel area was masked and excluded from calculation. The average fluorescence intensity inside the IS region was calculated by measuring the ratio of fluorescence signal intensity to the area of region of interest.
Lentiviral Vectors Design and Production
Lentiviral vectors were constructed to induce expression of mouse TG2 or mouse FXIII (see Table I in the online-only Data Supplement for gene identifiers of TG2 and FXIII). Mouse TG2 and mouse FXIII were isolated from uterine cDNA restrictionfree cloning using primers containing complementary overhangs to the designated target vector LV-GFP (Table II in the online-only Data Supplement). The purified PCR products were cloned into the lentiviral expression vector, LV-GFP (provided by Dr Oded Singer, Weizmann Institute of Science, Israel). To efficiently knockout of TG2 or FXIII, 2 single guide RNA (sgRNA) targeting TG2 or FXIII were used (Table II in the online-only Data Supplement). The guides were chosen to maximize on target scores and minimize off-target scores using several CRISPR designing tools, including the MIT CRISPR design tool 32 and sgRNA Designer, Rule Sets 1 and 2, 33, 34 in both the original sites and in the Benchling implementations websites (www.benchling.com), SSC (sequence scan for CRISPR), 35 and sgRNA scorer. 36 The sgRNA guide sequences were cloned into lentiCRISPR v2 lentiviral vector (Dr Igor Ulitsky and Dr Yoav Lubelsky, Weizmann Institute, Israel) according to Sanjana et al 37 with slight modifications. Briefly, oligonucleotides for the TG2 or FXIII sgRNA guide sequences were phosphorylated using T4 PNK (NEB, Ipswich, MA) for 30 minutes at 37°C, then annealed by heating to 95°C for 5 minutes and cooled down to 25°C at 5°C/min. The lentiCRISPR v2 vector and the annealed oligos were then supplemented with FastDigest BsmBI (Thermo Fisher Fermentas, Waltham, MA) and T7 ligase (NEB, Ipswich, MA) by 6 cycles of 5 minutes at 37°C followed by 5 minutes at 23°C. The ligation reaction was next treated with PlasmidSafe exonuclease (NEB, Ipswich, MA) for 30 minutes at 37°C. Recombinant lentiviruses were produced by transient transfection 38 in HEK293FT cells (Invitrogen, Carlsbad, CA) using 3 envelope and packaging plasmids and one of the following viral construct: TG2-LV-GFP (TG2 overexpression), TG2-CRISPR-v2 (TG2 depletion), FXIII-LV-GFP (FXIII overexpression), FXIII-CRISPR-v2 (FXIII depletion), Control-LV-GFP (LV-GFP vector without insert), or Control-CRISPR-v2 (lenti-CRISPR v2 vector without insert). Viral supernatants were harvested 48-hour post-transfection and filtered through a 0.45 µm pore cellulose acetate filters and concentrated by ultracentrifugation. Lentiviral supernatant titers were determined by Lenti-X p24 Rapid Titer Kit ( Table II in 
TG2 and FXIII Overexpression Validation
Validation was conducted using Western Blot analysis ( Figure 2D ). HEK293FT cells at 90% confluence were seeded in a 6 well plate. The next day cells were infected by the constructed lentivirus: TG2-LV-GFP, FXIII-LV-GFP, or Control-LV-GFP. The following day cells were harvested, and 50 µg of cell lysates were separated by 12% polyacrylamide SDS-PAGE. Protein fractions were transferred on ice to nitrocellulose membranes (100 V for 1 hour; Whatman, Dassel, Germany). Membranes were blocked by incubation with 20 % BSA and 0.1% Tween-20 in Tris buffered for 2 hours at room temperature. Western blot analysis was performed by incubating first with primary mouse monoclonal anti-TG2 or anti-FXIII antibodies (1:500; Abcam, Cambridge, United Kingdom), followed by secondary anti-mouse horseradish peroxidase conjugate (Jackson ImmunoResearch, West Grove, PA) and visualized with ECL (Pierce, Rockford, IL). In addition, blastocysts from all 3 groups were stained by whole-mount incubation with antibodies against TG2 ( Figure 2C ) and FXIII ( Figure 2D ), stained with specie specific secondary antibodies, Cy3 anti-mouse (1:1000; Jackson Immunoresearch Laboratories, West Grove, PA), counterstained with 4′,6-diamidino-2-phenylindole (DAPI; 1:1000; Vector Laboratories, Burlingame, CA), subsequently mounted in mineral oil. Images were taken using spinning disk 386 confocal microscope using ×40 magnification (Zeiss, Cell observer SD, Yena, Germany).
Generation of Surrogate Mice Carrying Embryos With Genetically Modified TC
All animal experiments were approved by the Animal Care and Use Committee of the Weizmann Institute (Approval numbers: 20510915-2 and 26130416-1). Follicle development was induced by pregnant mare's serum gonadotropin (5 IU sc; PMSG; Sigma-Aldrich, Rehovot, Israel) in 21 days old wild-type ICR female mice (Harlan, Jerusalem, Israel). After 48 hours, ovulation was induced by human chorionic gonadotropin (5 IU SC; hCG; Sigma-Aldrich, Rehovot, Israel). PMSG/hCGtreated female mice were housed overnight with wild-type ICR males, and the next morning the presence of a vaginal plug was examined (defined as embryonic day 0.5; E0.5). The female mice were euthanized 3 days later, and embryos at the morula or blastocyst stage were flushed out of the uteri. The embryos were incubated in potassium-supplemented simplex optimized medium to expand the blastocysts, and their Zona pellucida was removed in acidic Tyrode's solution. 39 Next, 20 to 40 embryos were incubated with lentiviruses in potassiumsupplemented simplex optimized medium for 6 hours at 37°C and subsequently were washed 4 times. 6 Before embryo transfer blastocysts (Figure 2A) expressing control vector or overexpressing TG2 or FXIII were visualized for GFP expression. Using Nonsurgical embryo transfer kit (NSET, ParaTechs, Lexington, KY), 10 blastocysts were transplanted into E2.5 pseudopregnant ICR female mouse. Pseudopregnancy was achieved by mating the wild-type ICR females with vasectomized males of proven sterility.
DCE-MRI Studies
DCE-MRI experiments were performed on a horizontal bore 9.4 T Biospec spectrometer using a linear coil for excitation and detection (Bruker BioSpin GmbH, Ettlingen, Germany), as previously reported. 10, 40, 41 Surrogate E6.5 pregnant mice carrying genetically modified embryos were serially scanned (each group consisted of 3-5 dams with 1-3 ISs). Mice were kept under respiratory monitoring while anesthetized by isoflurane (Abbott Laboratories, North Chicago, IL). The BSA-based macromolecular contrast material (biotin-BSA-GdDTPA [gadolinium diethylenetriaminepentaacetic acid]; 80 kDa; r=164 mmol/L −1 s −1 ; Symo-Chem, Eindhoven, the Netherlands), was administered via a tail vein catheter as bolus at 10 mg/mouse in 0.2 mL of PBS. Series of variable-flip-angle precontrast T1-weighted 3D gradient-echo images of the IS were acquired, before and sequentially 40 minutes after injecting the contrast agent. Variable-flip-angle precontrast T 1 -weighted 3D-gradient-echo images were acquired to determine the precontrast R 1 (repetition time: 10 ms; echo time: 2.8 ms; flip angles: 5°, 15°, 30°, 50°, and 70°; 2 averages; matrix: 256×256×64; field of view: 35×35×35 mm 3 ). The post-contrast images were obtained with a single flip angle (15°). Hyper permeable blood vessels were examined 40 minutes after biotin-BSA-GdDTPA injection ( Figure 3G through 3I, left side). Functional blood vessels were also confirmed in histological sections after intravenous injection of BSA labeled with 6-carboxy-X-rhodamine (BSA-ROX; 10 mg/mouse in 0.2 mL of PBS), 2 minutes before euthanizing the mice ( Figure 3G through 3I, right side) . BSA was labeled with rhodamine 5(6)-carboxy-X-rhodamine succinimidyl ester (BSA-ROX; Molecular Probes, Eugene, OR) as reported previously, 42 producing a labeling ranged between 2 to 4 fluorophores per protein molecule. Change in contrast agent concentration in the region of interest over time (C t ) was divided by its blood concentration (C blood ; extrapolated from vena cava region as time 0). Linear regression of these temporal changes in C t / C blood yielded 2 vascular parameters: Fractional blood volume (fBV=C 0 /C blood ) describes blood vessel density and is derived from the extrapolated concentration of the contrast agent in the IS at time zero, divided by the measured concentration in the vena cava, ≈5 minutes after intravenous administration. Permeability surface area product (PS=[C t −C 0 ]/[C blood ×t]) depicting rate of contrast agent extravasation from blood vessels and its accumulation in the interstitial space, was derived from the slope of the linear regression of the first 15 minutes after contrast material administration (t=15). Mean fractional blood volume and PS were calculated separately for single IS.
Statistical Analysis
All experiments were repeated at least 3× using GraphPad Prism software version 8.0.0 for Windows (GraphPad Software, San Diego, CA, www.graphpad.com). Statistically significant differences between experimental groups were analyzed with nonparametric post hoc test (Tukey-Kramer), as it was not normally distributed according to the Shapiro-Wilk test. The number of dams and ISs of each experiment indicated accordingly. Data are presented as mean±SD with P values <0.05 considered significant.
RESULTS
TG Expression and Enzymatic Activity in Embryo ISs
ISs at E5.5 (Figure 1 ) and E6.5 (Figure 2) were characterized for the localization and activity of TG2 and FXIII. At E5.5, TG2 was detected in TC ( Figure 1A) while FXIII was detected within the implantation chamber (Figure 1E ). TG2 and FXIII activity in vivo was assessed on frozen sections derived from IS after intravenous injection of T29-B ( Figure 1B) or F11-B ( Figure 1F ) to E5.5 pregnant mice. Total TG2 and FXIII activities was detected in situ by exposing fresh sections of nontreated IS to T29-B ( Figure 1C ) or F11-B ( Figure 1G ). Negative controls for T29-B ( Figure 1D ) or F11-B ( Figure 1H ) showed inconsiderable signals on in situ labeling with secondary antibodies without the SAs presence. On IS retrieved from E6.5 pregnant mice, TG2 (Figure 2A ) or FXIII ( Figure 2E ) were further detected on the secondary decidual zone contra-position the mesometrial side. Similar distribution pattern of T29-B (Figure 2A and 2C) or F11-B ( Figure 2F and 2G) on E6.5 IS was detected, after both intravenously in vivo and in situ administration of the SA. Nonspecific incorporation of T29-B ( Figure 2D ) or F11-B ( Figure 2H ) was negligible as demonstrated in situ using the TG inhibitor iodoacetamide. Comparison of IS on E5.5 and E6.5 revealed substantial changes in TG2 and FXIII localizations. While on E5.5, TG2 and FXIII were mainly localized around the embryo, their expression shifted toward the mesometrial side, concentrating at the IS boundaries. Interestingly, FXIII localization in IS on E5.5 was associated within cell nuclear surrounding the embryo. This unexpected association was not detected on E6.5.
MRI Reveals a Role for TG2 and FXIII in Maternal Angiogenesis During Embryo Implantation
The role of TG2 and FXIII with decidual vascular remodeling was examined by DCE-MRI of E6.5 surrogate pregnant mice carrying embryos with transgenic troph-ectoderm induced by lentiviral infection of blastocysts. Significantly low PS ( Figure 3J Figure 3C and 3F) . Fractional blood volume ( Figure 3K ) was reduced significantly at IS of embryos with TC overexpressing either FXIII or TG2. Accordingly, decreased histological labeling of biotin-BSA-GdDTPA was observed in IS with overexpressing TG2-( Figure 3G , left) or FXIII-( Figure 3H , left) TC, compared with IS with control vector (3I, left). As opposed to IS sections with TC overexpressing TG2 ( Figure 3G, right) or those expressing the control vector ( Figure 3I, right) , fluorescent BSA (BSA-ROX) was hardly detected in is with FXIII-overexpressing TC (Fig-Figure 3 . Impaired decidual vascular function of (implantation sites) ISs with genetically modified trophoblast cells (TC) overexpressing TG2 (tissue TG) or FXIII (factor XIII). ure 3H, right). PS values ( Figure 4J ) calculated from IS in which either TG2 ( Figure 4A and 4D) or FXIII ( Figure 4B and 4E) were depleted from TC using len-tiCRISPR v2 lentiviral vector were not significantly different from the control ( Figure 4C and 4F) . A significant increase in PS values was measured from IS with FXIII-depleted TC ( Figure 4K ) relative to the control IS and also to the values calculated from IS with TG2-depleted TC. While IS with TG2-depleted TC ( Figure 4K ) revealed no significant changes compared with the control values. Histological cross sections of these IS were used to corroborate the changes in blood volume and perme- ability detected by the MRI. In IS with TG2-depleted TC ( Figure 4G, left) , biotin-BSA-GdDTPA was mainly distributed in the secondary decidual zone. Slight reduction in BSA-ROX distribution was observed in IS with TG2depleted TC (Figure 4G , right) as compared with the control group ( Figure 4I, right) . Interestingly, the contrast agent was clearly detected in the embryonic niche of IS with FXIII-depleted TC ( Figure 4H ). IS vasculature was further characterized by CD34 (cluster of differentiation 34) staining for angiogenic neovasculature ( Figure 5 ). CD34 in control IS ( Figure 5A , 5C, 5E, and 5G) was distributed in a mesh-like pattern, arrayed intensely on the anti-mesometrial region. Vessels expressing CD34 were detected in IS with TC overexpressing TG2 ( Figure 5B ) or TG2-depleted TC ( Figure 5D ). The organized vascular structure visualized by CD34 labeling of the control IS ( Figure 5E ), could not be detected on IS with TC overexpressing FXIII ( Figure 5F ). CD34 staining was elevated in IS with FXIII-depleted TC ( Figure 5H ) relative to control ( Figure 5G ). Quantitative analysis of the detected CD34 signal intensity, showed no significant difference between IS with TC overexpressing TG2 ( Figure 5I ) or TG2-depleted TC ( Figure 5J ) compared with control sections. However, IS with TC overexpressing FXIII (Figure 5K ) demonstrated a significant lower signal intensity while, IS with FXIII-depleted TC ( Figure 5K ) had significant higher signal intensity than their control.
Fibrinogen and Collagen Intravenously Remodeling Is Mediated by FXIII During Implantation
Fibrinogen was clearly detected in the anti-mesometrial pole and adjacent to control embryonic TC (Figure 5A, upper part) . Increased fibrinogen deposition was detected in IS of FXIII-overexpressing TC, particularly in the IS circumference, while fibrinogen was diminished at the embryonic vicinity ( Figure 5B, upper part) , as compared with control. CIV localization on the control IS (Figure 5A , lower part) was confined to the anti-mesometrial pole and around the primary decidual zone, while a substantial wider partition was displayed on the FXIII overexpressed TC (Figure 5B, lower part) . Inversely to the IS with FXIII overexpressed TC, fibrinogen and CIV were hardly detected in IS with FXIII-depleted TC ( Figure 5D ) relative to control ( Figure 5C ).
DISCUSSION
In this study, MRI was applied for detection of the role of the 2 TG isoenzymes, TG2 and FXIII, in decidual angiogenesis during early embryo implantation ( Figure 6 ). TG2 and FXIII were expressed mostly at the feto-maternal interface and at the decidual anti-mesometrial pole at E5.5. and E6.5. Association between FXIII localization to cell nuclei was observed in the IS. Beyond the role of secreted FXIII in coagulation, it also mediates intranuclear cross-linking. 43 The role of TG isoenzymes on implantation was determined by manipulating TG2 and FXIII expression in embryonic TC. DCE-MRI showed reduced decidual vascular density in IS with TC overexpressing TG2, and elevated permeability in IS with TG2depleted TC ( Figure 6B ). Decidual vasculature did not show significant changes when TG2 was depleted from TC. DCE-MRI revealed that TC derived FXIII regulates decidual vascular density. Substantially, low fractional blood volume as well as low PS values were detected in IS where the TC overexpressed FXIII. IS with FXIIIdepleted TC showed increased transcapillary leakage with higher PS values ( Figure 6C ) than IS of embryonic TC infected with an empty control vector ( Figure 6A ). Embryo implantation failure is the primary cause for the low success of in vitro fertilization programs. 4 Impaired uterine hyperpermeability has been widely proposed as an important cause for implantation failure in humans. 44 Several complications of pregnancy, such as preeclampsia and intrauterine growth restriction, have been attributed to disturbances in early uterine blood supply 12 or impaired trophoblast invasion of the placental bed spiral arterioles later in pregnancy. 13 Therefore, it is important to characterize the processes regulating uterine extracellular-matrix remodeling and angiogenesis during implantation, and MRI (specifically DCE-MRI) is a powerful tool addressing research requirements.
In our study, fibrinogen appeared to be diminished at the feto-maternal interface of the FXIII overexpressed IS, while it was increased on the decidua circumference. On the contrary, CIV was highly detected in IS with FXIII overexpressed TC extending further into the decidua, while it was narrowly confined around the control's embryo. Both fibrinogen and CIV were hardly detected in the IS with FXIII-depleted TC. Our findings indicate that enhanced activity of FXIII is associated with CIV presence. The precise role of FXIII in changing the fibrinogen distribution pattern is unclear. It is possible that FXIII and CIV take part in anchoring the embryo to the endometrium as suggested by Asahina. 45 Association between abnormal expression levels of TG2 or FXIII (CD) to both reduced fertility and increased risk of adverse pregnancy-related events has been long documented. 46, 47 The activities of TG2 and FXIII were evaluated here using novel selective substrate analogs, T29-B and F11-B, respectively, suggesting their potential as molecular imaging probes in selective detection Figure 6 . The effect of trophoblast cell (TC) derived TG2 (tissue TG) or FXIII (factor XIII) on the decidual vascular function. A, Decidual blood vessels permeability and blood volume; Embryo TC infected by lentivirus to overexpressing TG2 (B, Left) or FXIII (C, Left), display a decrease in decidual blood volume. Overexpressing of FXIII also shows a significant decrease in decidual blood vessels permeability (C, Left); Decidual vasculature properties did not change when embryonic TC was depleted of TG2 (B, Right), while depletion of FXIII (C, Right) shows a significant increase in decidual blood volume. Red branched lines represent blood vessels density; ovals represent blood vessel permeability. of TG2 and FXIII. TG isoenzyme localization showed a direct correlation to their SA distribution. Establishment of implantation sites with genetically modified TC, enabled us to study the effect on maternal angiogenesis on TG2 and FXIII modulation. Our findings demonstrated that TC derived TG2 plays an important role in regulating decidual vascular permeability, while TC derived FXIII regulates vascular density as well as permeability. These findings suggest distinct roles for TG2 and FXIII during embryo implantation and may shed light on TG-reduced fertility. Moreover, MRI provides a modality of choice for high resolution in vivo imaging of the early stages of pregnancy, and particularly the maternal angiogenesis induced by the implanting embryo.
